POSSIBLE REVERSAL OF COGNITIVE DEFICITS IN A PATIENT WITH ALZHEIMER'S DISEASE
POSSIBLE REVERSAL OF COGNITIVE DEFICITS IN A PATIENT WITH ALZHEIMER'S DISEASE
批准号:
3741234
负责人:
MICHAEL GOLD
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
这项研究的目的是确定雌激素的使用是否会
英文摘要
It is the purpose of this study to determine if the use of estrogen will
improve cognition in patients with Alzheimer's Disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IGF::OT::IGF PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS TASK ORDER #001 - PERFORMANCE AREA A - ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT
-
批准号:10881609
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2023
-
负责人:MICHAEL GOLD
-
依托单位:
IGF::OT::IGF PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS TASK ORDER #001 - PERFORMANCE AREA A - ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT
-
批准号:10658956
-
项目类别:
-
资助金额:$5.37万
-
财政年份:2022
-
负责人:MICHAEL GOLD
-
依托单位:
IGF::OT::IGF PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS TASK ORDER #001 - PERFORMANCE AREA A - ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT
-
批准号:10162362
-
项目类别:
-
资助金额:$5.16万
-
财政年份:2016
-
负责人:MICHAEL GOLD
-
依托单位:
IGF::OT::IGF PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS TASK ORDER #001 - PERFORMANCE AREA A - ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT
-
批准号:10444892
-
项目类别:
-
资助金额:$5.26万
-
财政年份:2016
-
负责人:MICHAEL GOLD
-
依托单位:
IGF::OT::IGF PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS TASK ORDER #001 - PERFORMANCE AREA A - ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT
-
批准号:9376333
-
项目类别:
-
资助金额:$7.23万
-
财政年份:2016
-
负责人:MICHAEL GOLD
-
依托单位: